financetom
Business
financetom
/
Business
/
Market Chatter: Qualys Exploring Potential Sale
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Qualys Exploring Potential Sale
Nov 9, 2024 11:33 AM

02:24 PM EST, 11/06/2024 (MT Newswires) -- Qualys ( QLYS ) is exploring options that include a possible sale after receiving takeover interest, Bloomberg reported Wednesday, citing people familiar with the matter.

The cybersecurity company did not immediately reply to a request for comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 162.48, Change: +34.25, Percent Change: +26.71

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Gray Media, Atlanta Braves Partner on Game Broadcasts Starting 2025
Gray Media, Atlanta Braves Partner on Game Broadcasts Starting 2025
Dec 18, 2024
09:02 AM EST, 12/18/2024 (MT Newswires) -- Gray Media (GTN) and Atlanta Braves ( BATRA ) have signed a multi-year partnership beginning in 2025 to simulcast 15 regular-season games with FanDuel Sports Network, Gray Media said Wednesday. Additionally, Gray said it will exclusively produce and broadcast 10 spring training games. ...
Guardant Health, Boehringer Collaborate on Companion Test for Potential Lung Cancer Drug
Guardant Health, Boehringer Collaborate on Companion Test for Potential Lung Cancer Drug
Dec 18, 2024
08:59 AM EST, 12/18/2024 (MT Newswires) -- Guardant Health ( GH ) said Wednesday that it is collaborating with German pharmaceutical company Boehringer Ingelheim to seek regulatory approval and commercialize Guardant360 CDx liquid biopsy test as a companion diagnostic for Boehringer's investigational non-small cell lung cancer drug zongertinib. Under the collaboration, Guardant said its Guardant360 CDx blood test would provide...
Toro Fiscal Q4 Adjusted Earnings, Net Sales Rise; Fiscal 2025 Non-GAAP EPS, Revenue Growth Guidance Issued
Toro Fiscal Q4 Adjusted Earnings, Net Sales Rise; Fiscal 2025 Non-GAAP EPS, Revenue Growth Guidance Issued
Dec 18, 2024
09:02 AM EST, 12/18/2024 (MT Newswires) -- The Toro Co. ( TTC ) reported fiscal Q4 adjusted earnings Wednesday of $0.95 per diluted share, up from $0.71 a year earlier. Analysts polled by FactSet expected $0.95. Net sales for the quarter ended Oct. 31 were $1.08 billion, compared with $983.2 million a year earlier. Analysts surveyed by FactSet expected $1.09...
General Mills Lowers Fiscal 2025 Earnings Outlook Despite Second-Quarter Beat
General Mills Lowers Fiscal 2025 Earnings Outlook Despite Second-Quarter Beat
Dec 18, 2024
08:57 AM EST, 12/18/2024 (MT Newswires) -- General Mills ( GIS ) lowered its full-year earnings outlook on Wednesday as it increases investments to improve volume and market share trends, even though the packaged foods maker recorded better-than-expected fiscal second-quarter results. The company now expects adjusted earnings to be down 1% to 3% in constant currency terms for fiscal 2025,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved